Chemoinformaics analysis of DIBENZYL DISULFIDE
| Molecular Weight | 246.4 | nRot | 5 |
| Heavy Atom Molecular Weight | 232.288 | nRig | 12 |
| Exact Molecular Weight | 246.054 | nRing | 2 |
| Solubility: LogS | -4.863 | nHRing | 0 |
| Solubility: LogP | 4.116 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 38.5151 |
| nHD | 0 | BPOL | 16.5049 |
| QED | 0.55 |
| Synth | 1.798 |
| Natural Product Likeliness | -0.154 |
| NR-PPAR-gamma | 0.037 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.003 |
| HIA | 0.011 |
| CACO-2 | -4.427 |
| MDCK | 0.0000148 |
| BBB | 0.843 |
| PPB | 0.966627 |
| VDSS | 1.308 |
| FU | 0.0202206 |
| CYP1A2-inh | 0.924 |
| CYP1A2-sub | 0.524 |
| CYP2c19-inh | 0.961 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.875 |
| CYP2c9-sub | 0.096 |
| CYP2d6-inh | 0.37 |
| CYP2d6-sub | 0.27 |
| CYP3a4-inh | 0.532 |
| CYP3a4-sub | 0.639 |
| CL | 13.73 |
| T12 | 0.454 |
| hERG | 0.147 |
| Ames | 0.782 |
| ROA | 0.007 |
| SkinSen | 0.957 |
| Carcinogencity | 0.43 |
| EI | 0.991 |
| Respiratory | 0.423 |
| NR-Aromatase | 0.029 |
| Antiviral | No |
| Prediction | 0.607087 |